Graded against 178,763 supplements and 757 reviewed supplement and medication pairs, sourced from PubMed, FDA CAERS, openFDA, NIH DSLD
Boswellia
BotanicalLast updated April 2026
AVELOR SUMMARY
Boswellia serrata extract contains boswellic acids, potent anti-inflammatory compounds that inhibit 5-lipoxygenase (5-LOX), a pathway not targeted by NSAIDs or COX inhibitors.
Our research shows strong evidence for osteoarthritis pain relief and moderate evidence for inflammatory bowel disease.
It works through a different mechanism than ibuprofen, making it a potential complement, not a replacement, for conventional anti-inflammatory therapy.
EVIDENCE GRADES
Osteoarthritis (knee pain)
Moderate evidenceGrade B+
Inflammatory bowel disease (UC/Crohn's)
Moderate evidenceGrade B-
Asthma
Limited evidenceGrade C+
Rheumatoid arthritis
Limited evidenceGrade C+
Brain tumor (adjunct, Boswellia sacra)
Limited evidenceGrade C
WHAT IT DOES
Boswellic acids (AKBA, acetyl-11-keto-β-boswellic acid is the most active) specifically inhibit 5-lipoxygenase, the enzyme that produces leukotrienes. Leukotrienes are inflammatory mediators involved in asthma, allergies, and chronic inflammatory conditions. This mechanism is unique, NSAIDs target COX-1/COX-2, corticosteroids broadly suppress immune function, but boswellia specifically targets the 5-LOX pathway.
AKBA also inhibits NF-κB, human leukocyte elastase, and microsomal prostaglandin E2 synthase. The anti-inflammatory effect is potent but narrower than corticosteroids.
OPTIMAL DOSAGE
Standard Boswellia serrata extract (65% boswellic acids): 300-500mg 3x/day
5-LOXIN/AprèsFlex (30% AKBA): 100-250mg/day
Aflapin (enriched AKBA): 100mg/day
Duration: 4-8 weeks for full anti-inflammatory effect
Independently graded against 178,763 indexed supplements and 757 reviewed supplement and medication pairs, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.